
|Articles|March 22, 2004
Antipsychotics, obesity, diabetes: Breaking the lock
Second-generation antipsychotics (SGAs), while clinically better than their earlier counterparts, have been associated with dramatic weight gain, diabetes and an atherogenic lipid profile.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Severe COVID-19 Increases Stroke Risk for Patients With Asthma
2
Coming Full Circle: How Mike Brundage Built a Thriving Pharmacy in Rural Pennsylvania
3
Pharmacists Help Patients Stay Adherent to COPD Therapy, Improving Overall Quality of Life
4
FDA Approves First 1-Minute Self Test for HIV
5